Kure Advisory’s Eli Lilly LLY Stock Holding History

Kure Advisory’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-749	Closed	-$437K	–	85
2023 Q4	$437K	Sell	749 -13	-2%	-$7.59K	0.23%	54
2023 Q3	$409K	Buy	+762	New	+$393K	0.23%	55

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kure Advisory's LLY Position: Q1 2024 in Review

Kure Advisory sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 749 shares — an estimated $437K sold.

Kure Advisory first reported a position in LLY in Q3 2023 and held it in 2 quarters. The position peaked at $437K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

Kure Advisory reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
Kure Advisory sold 749 Eli Lilly shares in Q1 2024, an estimated $437K.
Kure Advisory first reported a position in Eli Lilly in Q3 2023 and held it in 2 quarters.
Kure Advisory's Eli Lilly position peaked at $437K in Q4 2023.
3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Kure Advisory's 13F filing for Q1 2024, filed 9 May 2024.